Full Paper
CDCl3): d=149.83, 129.10, 128.54, 124.84, 124.72, 121.09 (all aro-
matic C), 55.35 ppm (ArCH2N); MS (ESI, MeOH): m/z calcd: 540.9
[M]+; found: 541. elemental analysis calcd (%) for C21H15NO3Cl6: C
46.53, H 2.79, N 2.58; found: C 46.73, H 2.73, N 2.57.
due was purified by column chromatography (EtOAc/hexane,
20:80 v/v) to yield a yellow powder (721 mg, 68%). 1H NMR
3
4
(400 MHz, 298 K, CDCl3): d=8.04 (dd, JHH =8.9 Hz, JHH =2.8 Hz 1H,
4
4
ArH), 7.96 (d, JHH =2.8 Hz, 1H, ArH), 7.24 (d, JHH =2.4 Hz, 2H, ArH),
4
3
Al complex 5[22a]: [AlMe3] (2m in heptane, 1.19 mL, 2.38 mmol) was
slowly added to a solution of ligand precursor 1 (1.0 g, 2.38 mmol)
in THF (20 mL). The solution was stirred at RT for 2 h and then con-
centrated. Hexane was added to the concentrate resulting in pre-
cipitation of the complex, which was isolated by filtration and fur-
ther dried under vacuum to yield a white powder (963 mg, 78%).
6.98 (d, JHH =2.4 Hz, 2H, ArH), 6.86 (d, JHH =8.9 Hz, 1H, ArH), 5.91
(brs, 3H, ArOH), 3.85 (s, 2H, ArCH2N), 3.78 (s, 4H, ArCH2N), 1.41 (s,
18H, ArC(CH3)3), 1.28 ppm (s, 18H, ArC(CH3)3); 13C{1H} NMR
(125 MHz, 298 K, CDCl3): d=162.40, 151.31, 142.59, 140.41, 135.92,
126.45, 125.69, 125.62, 124.20, 123.19, 121.68, 116.73 (all aromatic
C), 57.68, 56.94 (both ArCH2N), 34.60, 34.19 (both ArC(CH3)3), 31.55,
29.88 ppm (both ArC(CH3)3); MS (ESIꢀ, MeOH): m/z calcd: 603.4
[MꢀH]ꢀ; found: 603; elemental analysis calcd (%) for
3
1H NMR (400 MHz, 298 K, CDCl3): d=6.90 (d, JHH =1.4 Hz, 3H, ArH),
3
2
6.63 (d, JHH =1.4 Hz, 3H, ArH), 4.59 (br, 4H, THF), 4.28 (br d, JHH
=
C37H52N2O5·1= H2O: C 72.40, H 8.70, N 4.56; found: C 72.57, H 8.63,
13.5 Hz, 3H, ArCH2N), 2.86 (br d, 2JHH =13.5 Hz, 3H, ArCH2N), 2.22
(s, 9H, ArCH3), 2.21 (s, 9H, ArCH3), 2.18 ppm (br, 4H, THF); 13C{1H}
NMR (125 MHz, 298 K, CDCl3): d=154.29, 131.02, 126.97, 126.89,
125.83, 120.63 (all aromatic C), 71.31 (THF), 58.67 (ArCH2N), 25.60
(THF), 20.40 (ArCH3), 16.98 ppm (ArCH3); MS (MALDI+, dctb): m/z
calcd: 443.2 [MꢀTHF]+; found: 443.
2
N 4.47.
Al complex 12: This compound was prepared in a similar manner
to 5 by treatment of 11 (500 mg, 0.82 mmol) with [AlMe3] (2m in
heptane, 0.41 mL, 0.82 mmol) to yield a white powder (422 mg,
78%). Crystals suitable for single-crystal X-ray diffraction studies
were obtained by layering of a concentrated THF solution of the
complex with hexane. 1H NMR (400 MHz, 298 K, [D5]pyridine): d=
Al complex 6[22b]: This compound was prepared in a similar
manner to 5 by treatment of ligand precursor 2 (1.0 g, 1.49 mmol)
with [AlMe3] (2m in heptane, 0.75 mL, 1.49 mmol) to yield a white
powder (869 mg, 76%). 1H NMR (400 MHz, 298 K, CDCl3): d=7.25
3
4
4
8.27 (dd, JHH =8.9, JHH =2.8 Hz, 1H, ArH), 8.13 (d, JHH =2.8 Hz, 1H,
ArH), 7.51 (d, 4JHH =2.3 Hz, 2H, ArH), 7.12 (brs, 2H, ArH), 7.03 (d,
3JHH =8.9 Hz, 1H, ArH), 4.15 (brs, 3H, ArCH2N), 3.25 (brs, 3H,
ArCH2N), 1.43 (s, 18H, ArC(CH3)3), 1.34 ppm (s, 18H, ArC(CH3)3);
13C{1H} NMR (125 MHz, 298 K, [D5]pyridine): d=165.44, 155.13,
139.77, 139.07, 137.48, 135.53, 125.82, 125.75, 124.30, 123.70,
123.53, 119.59 (all aromatic C), 58.83, 56.90 (both ArCH2N), 34.61,
34.11 (both ArC(CH3)3), 31.71, 29.52 ppm (both ArC(CH3)3); m/z
calcd: 628.35 [M]+; found: 628.4; elemental analysis calcd (%) for
3
3
(d, JHH =2.5 Hz, 3H, ArH), 6.87 (d, JHH =2.5 Hz, 3H, ArH), 4.36–4.27
(m, 7H; overlapping ArCH2N and THF), 2.95 (brs, 3H, ArCH2N), 2.06
(m, 4H, THF), 1.43 (s, 27H, ArC(CH3)3), 1.29 ppm (s, 27H, ArC(CH3)3);
13C{1H} NMR (125 MHz, 298 K, CDCl3): d=154.82, 139.37, 137.11,
123.78, 123.60, 121.43 (all aromatic C), 70.26 (THF), 58.83 (ArCH2N),
34.88 (ArC(CH3)3), 34.03 (ArC(CH3)3), 31.71 (ArC(CH3)3), 29.70
(ArC(CH3)3), 25.42 ppm (THF); MS (MALDI+, dctb): m/z calcd: 695.5
[MꢀTHF]+; found: 695.
C37H49N2O5Al·H2O·1= (C6H14): C 69.64, H 8.47, N 3.91; found: C 69.59,
2
H 8.78, N 3.80.
Al complex 7: This compound was prepared in a similar manner to
5 by treatment of ligand precursor 3 (350 mg, 1.04 mmol) with
[AlMe3] (2m in heptane, 0.51 mL, 1.04 mmol) to yield a white
1
Typical catalysis procedure
powder (286 mg, 76%). H NMR (400 MHz, 298 K, [D5]pyridine): d=
3
4
3
7.37 (ddd, JHH =7.6 and 7.7, JHH =1.5 Hz, 3H, ArH), 7.18 (dd, JHH
=
1,2-epoxyhexane (1.0 g), the aluminium complex (0.005 mol%),
and Bu4NI (0.025 mol%) were charged into a stainless steel auto-
clave (30 mL). The autoclave was then subjected to three cycles of
pressurization and depressurization with CO2 (0.5 MPa, 5 bar),
before final stabilization of the pressure to 1.0 MPa (10 bar). The
autoclave was sealed and heated to the required temperature and
left stirring for 2 h. An aliquot of the resulting mixture was taken
7.6, 4JHH =1.5 Hz, 3H, ArH), 7.06 (dd, 3JHH =7.7, 4JHH =0.9 Hz, 3H,
3
4
ArH), 6.92 (ddd, JHH =7.6 and 7.7, JHH =0.9 Hz, 3H, ArH), 4.49 (brs,
3H, ArCH2N), 3.14 ppm (brs, 3H, ArCH2N); 13C{1H} NMR (125 MHz,
298 K, [D5]pyridine): d=160.21, 130.77, 130.52, 123.50, 120.69,
119.09 (all aromatic C), 59.46 ppm (ArCH2N); MS (MALDI+, dctb):
m/z calcd: 359.11 [M]+; found: 359.4; elemental analysis calcd (%)
for C21H18NO3Al·H2O·1= (C6H14): C 67.74, H 5.94, N 3.51; found: C
4
1
and conversion analyzed by means of H NMR spectroscopy using
67.41, H 5.95, N 3.25.
CDCl3 as the solvent. The identity of the cyclic carbonate product
was confirmed by comparison to previously reported literature
values. For a photo of the reactor please refer to the Supporting
Information.
Al complex 8: This compound was prepared in a similar manner
to 5 by treatment of ligand precursor 4 (500 mg, 0.92 mmol) with
[AlMe3] (2m in heptane, 0.46 mL, 0.92 mmol) to yield a white
powder (350 mg, 60%). Crystals suitable for single-crystal X-ray dif-
fraction studies were obtained by layering of a concentrated THF
solution of the complex with hexane. 1H NMR (400 MHz, 298 K,
Kinetic experiments
3
3
CDCl3): d=7.33 (d, JHH =2.6 Hz, 3H, ArH), 6.90 (d, JHH =2.6 Hz, 3H,
2
ArH), 4.69 (m, 4H, THF), 4.18 (br d, JHH =13.3 Hz, 3H, ArCH2N), 2.95
The AMTEC vessels were charged with NBu4I and connected to the
hardware. A leak test was first performed with 1.5 MPa (15 bar) of
CO2, with the pressure finally reduced to 0.2 MPa (2 bar). The reac-
tors were filled with 0.4 MPa (4 bar) of CO2, and degassed to 2 bar,
and this cycle was repeated three times. A solution of the Al cata-
lyst 8 in 1,2-epoxyhexane 13 (1.20 mL) was injected into the reac-
tion vessel, the pressure was raised to 1.5 MPa (15 bar), and the
temperature was set to 308C. The reactions were stirred for 2 h at
600 rpm. The stirrer was then stopped and degassed. Hereafter, an
aliquot of the resultant reaction mixture was taken and the conver-
sion was determined by means of 1H NMR spectroscopy using
CDCl3 as the solvent. For a photo of the reactor system please
refer to the Supporting Information.
(br d, 2JHH =13.3 Hz, 3H, ArCH2N), 2.23 ppm (m, 4H, THF); 13C{1H}
NMR (125 MHz, 298 K, CDCl3): d=152.46, 129.75, 127.13, 124.68,
123.08, 122.16 (all aromatic C), 72.38 (THF), 58.25 (ArCH2N),
25.48 ppm (THF); MS (MALDI+, dctb): m/z calcd: 564.9 [MꢀTHF]+;
found: 565; elemental analysis calcd (%) for C25H20AlCl6NO4: C
47.05, H 3.16, N 2.19; found: C 46.75, H 3.22, N 2.12.
Ligand precursor 11: NEt3 (123 mL, 1.76 mmol) was added with
stirring to a solution of 6,6’-(azanediyl-bis(methylene))-bis(2,4-di-
tert-butylphenol) (0.80 g, 1.76 mmol) and 2-(bromomethyl)-4-nitro-
phenol (204 mg, 1.76 mmol) in THF (20 mL). The reaction mixture
was stirred at reflux temperature for 18 h and filtered after cooling.
The volatiles were removed from the filtrate and the obtained resi-
Chem. Eur. J. 2014, 20, 2264 – 2275
2273
ꢂ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim